PINK1 IVS5-5 G > a polymorphism may contribute to the risk of late onset Parkinson disease in Chinese

Chinese Journal of Medical Genetics

Volumn 24, Issue 3, 2007, Pages 305-309

  Wang, Feng ^a,b,c   Chen, Biao ^a,b,c   Feng, Xiu Li ^c   Zou, Hai Qiang ^b   Ma, Jing Hong ^a   Dong, Xiu Min ^b   Li, Yongjie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

^c Chinese National Human Genome Research Center   (China)

Author keywords

Association study; Genetic susceptibility; Parkinson disease; PINK1 gene; Single nucleotide polymorphism

Indexed keywords

PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PTEN INDUCED KINASE 1; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; COMPUTER MODEL; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INTRON; MAJOR CLINICAL STUDY; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE DISTRIBUTION; AGE OF ONSET; AGED; AGED, 80 AND OVER; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PARKINSON DISEASE; POLYMORPHISM, GENETIC; PROTEIN KINASES; SEX DISTRIBUTION;

EID: 34250815082     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 2004,304: 1158-1160.
2. Bonifati V, Rohe CF, Breedveld GJ, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology, 2005, 65:87-95.
3. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol, 2004, 56:336-341.
4. Hatano Y, Li Y, Sato K, et al. Novel PINK1 mutations in early-onset parkinsonism. Ann Neurol, 2004, 56:424-427.
5. Tan EK, Yew K, Chua E, et al. PINK1 mutations in sporadic early-onset Parkinson's disease. Mov Disord, 2006,21:789-793.
6. Fung HC, Chen CM, Hardy J, et al. Analysis of the PINK1 gene in a cohort of patients with sporadic early-onset parkinsonism in Taiwan. Neurosci Lett, 2006, 394:33-36.
7. Ibanez P, Lesage S, Lohmann E, et al. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain, 2006, 129:686-694.
8. Zhang YH, Tang BS, Guo JF, et al. Mutation analysis of PINK1 gene in Chinese patients with autosomal recessive early-onset parkinsonism type 6. Natl Med J Chin, 2005, 85:1538-1541.
9. Langston JW, Widner H, Goetz CG, et al. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord, 1992,7:2-13.
10. Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinico-pathological study. Neurology, 1992,42:1142-1146.
11. Wolford JK, Blunt D, Ballecer C, et al. High-throughput SNP detection by using DNA pooling and denaturing high performance liquid chromatography (DHPLC). Hum Genet, 2000,107:483-487.
12. Pals P, Lincoln S, Manning J, et al. alpha-Synuclein promoter confers susceptibility to Parkinson's disease. Ann Neurol, 2004,56:591-595.
13. Liu Y, Fallon L, Lashuel HA, et al. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell, 2002, 111:209-218.
14. West AB, Maraganore D, Crook J, et al. Functional association of the parkin gene promoter with idiopathic Parkinson's disease. Hum Mol Genet, 2002,11:2787-2792.
15. Oliveira SA, Scott WK, Martin ER, et al. Parkin mutations and susceptibility alleles in late onset Parkinson's disease. Ann Neurol, 2003,53:624-629.
16. Foroud T, Uniacke SK, Liu L, et al. Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson's disease. Neurology, 2003,60: 796-801.
17. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet, 2005,365:415-416.
18. Pagani F, Buratti E, Stuani C, et al. A new type of mutation causes a splicing defect in ATM. Nat Genet, 2002, 30:426-429.
19. Albanese A, Valente EM, Romito LM, et al. The PINK1 phenotype can be indistinguishable from idiopathic Parkinson disease. Neurology, 2005, 64:1958-1960.
20. Ars E, Serra E, Garcia J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis typel. Hum Mol Genet, 2000, 9:237-247.
21. Yamaguchi S, Shinmura K, Saitoh T, et al. A single nucleotide polymorphism at the splice donor site of the human MYH base excision repair genes results in reduced translation efficiency of its transcripts. Genes Cells, 2002,7:461-474.
22. Silvestri L, Caputo V, Bellacchio E, et al. Mitochondrial import and enzymatic activity of PINK1 mutants associated to recessive parkinsonism. Hum Mol Genet, 2005, 14:3477-3492.
23. Petit A, Kawarai T, Paitel E, et al. Wild-type PINK1 prevents basal and induced neuronal apoptosis, a protective effect abrogated by Parkinson's disease-related mutations. J Biol Chem, 2005, 280:34025-34032.
24. Hicks AA, Petursson H, Jonsson T, et al. A susceptibility gene for late-onset idiopathic Parkinson's disease. Ann Neurol, 2002,52:549-555.